Risk factors for the development of significant postoperative bleeding after pediatric cardiac surgery with cardiopulmonary bypass: A nested case-control study

Background: Postoperative bleeding of more than 10% of circulating blood volume (CBV) within the first six hours after a cardiac surgery with cardiopulmonary bypass (CBS) is one of the most frequent complications associated with postoperative morbidity and mortality in children. Objectives: This study aimedto identify specific risk factors for the development of this complication in a subpopulation of Mexican pediatric patients. Methods: A nested case-control study was conducted at a tertiary level pediatric intensive care unit (PICU) of Mexico City. Cases were those children who developed bleeding of more than 10% of circulating blood volume (CBV) within the first six hours after the surgery and controls were all those children who did not presented this complication. Bivariate and logistic regression analyses were performed. A P-value less than 0.05 was considered as statistically significant. Results: Results showed that 33% (n = 21) of included children developed significant bleeding in the first six hours after the cardiac surgery. The main risk factors for developing this complication were the cyanotic congenital heart disease (P < 0.01), bypass time exceeding 90 minutes (P < 0.01), aortic clamping time > 60 minutes (P = 0.01), intraoperative bleeding volume (P = 0.04), and an initial activated clotting time > 140 seconds (P < 0.01). Conclusions: An important proportion of patients developed postoperative significant bleeding. Risk factors identified in the present study could help to identify and close monitor a subgroup of children at high risk for the development of this complication.

[1]  D. Faraoni,et al.  Multivariate model for predicting postoperative blood loss in children undergoing cardiac surgery: a preliminary study. , 2014, British journal of anaesthesia.

[2]  D. Faraoni,et al.  Factors affecting postoperative blood loss in children undergoing cardiac surgery , 2014, Journal of Cardiothoracic Surgery.

[3]  K. Sørensen,et al.  Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. , 2013, International journal of cardiology.

[4]  A. Hanke,et al.  Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. , 2013, The Journal of thoracic and cardiovascular surgery.

[5]  L. Cohn,et al.  Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients , 2012, Anesthesiology.

[6]  S. Ostrowski,et al.  Coagulopathy and hemostatic monitoring in cardiac surgery: An update , 2012, Scandinavian cardiovascular journal : SCJ.

[7]  Y. Hayata,et al.  Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery , 2011, Paediatric anaesthesia.

[8]  G. Theilmeier,et al.  Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[10]  A. Valenzuela-Flores,et al.  [Physiopathological alterations secondary to extracorporeal circulation in cardiac surgery]. , 2005, Cirugia y cirujanos.

[11]  C. Ludlam,et al.  Individualized heparin and protamine management in infants and children undergoing cardiac operations. , 2001, The Annals of thoracic surgery.

[12]  L. F. Pineda,et al.  Guías de práctica clínica de la Sociedad Española de Cardiología en el postoperado de cardiopatía congénita , 2000 .

[13]  J. Levy,et al.  Rapid Evaluation of Coagulopathies After Cardiopulmonary Bypass in Children Using Modified Thromboelastography , 2000, Anesthesia and analgesia.

[14]  S. Bratton,et al.  Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. , 1999, Anesthesia and analgesia.

[15]  S. Bratton,et al.  Association between age and blood loss in children undergoing open heart operations. , 1998, The Annals of thoracic surgery.

[16]  K. Kanter,et al.  Predicting and Treating Coagulopathies After Cardiopulmonary Bypass in Children , 1997, Anesthesia and analgesia.

[17]  S. Bélisle,et al.  Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. , 1996, The Annals of thoracic surgery.

[18]  P. Laussen Critical Heart Disease in Infants and Children , 1995 .

[19]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[20]  D. Komp,et al.  Polycythemia in cyanotic heart disease--a study of altered coagulation. , 1970, The Journal of pediatrics.

[21]  S. Kontras,et al.  Hematologic abnormalities in children with congenital heart disease. , 1966, JAMA.

[22]  J. Ortega-Ramírez,et al.  Alteraciones fisiopatólogicas secundarias a circulación extracorpórea en cirugía cardíaca , 2005 .

[23]  L. Fernández Pineda,et al.  [Practice Guidelines of the Spanish Society of Cardiology in the postoperative course of congenital heart diseases]. , 2000, Revista espanola de cardiologia.